000 | 01797 a2200553 4500 | ||
---|---|---|---|
005 | 20250511151747.0 | ||
264 | 0 | _c19770125 | |
008 | 197701s 0 0 eng d | ||
022 | _a0007-1447 | ||
024 | 7 |
_a10.1136/bmj.2.6044.1100 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAber, C P | |
245 | 0 | 0 |
_aStreptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. _h[electronic resource] |
260 |
_bBritish medical journal _cNov 1976 |
||
300 |
_a1100-4 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xcomplications |
650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
650 | 0 | 4 |
_aHeart Arrest _xcomplications |
650 | 0 | 4 |
_aHemorrhage _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aStreptokinase _xadministration & dosage |
650 | 0 | 4 |
_aThromboembolism _xcomplications |
650 | 0 | 4 | _aUnited Kingdom |
700 | 1 | _aBass, N M | |
700 | 1 | _aBerry, C L | |
700 | 1 | _aCarson, P H | |
700 | 1 | _aDobbs, R J | |
700 | 1 | _aFox, K M | |
700 | 1 | _aHamblin, J J | |
700 | 1 | _aHaydu, S P | |
700 | 1 | _aHowitt, G | |
700 | 1 | _aMacIver, J E | |
700 | 1 | _aPortal, R W | |
700 | 1 | _aRaftery, E B | |
700 | 1 | _aRousell, R H | |
700 | 1 | _aStock, J P | |
773 | 0 |
_tBritish medical journal _gvol. 2 _gno. 6044 _gp. 1100-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.2.6044.1100 _zAvailable from publisher's website |
999 |
_c802621 _d802621 |